Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.
about
Role of systemic chemotherapy in urothelial urinary bladder cancerPaclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma.Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinoma.Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis.Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin TreatmentFirst- and second-line therapy for metastatic urothelial carcinoma of the bladderUse of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis.Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysis.Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.Vinflunine in the treatment of advanced bladder cancer.Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.Chemotherapy for bladder cancer in patients with impaired renal function.Second-line systemic therapy for metastatic urothelial carcinoma of the bladder.Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis.Assessment of genetic and epigenetic variation during long-term Taxus cell culture.Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy.Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].Clinical Impact of Consolidative and Salvage Radiotherapy for Lymph Node Metastasis in Upper Urinary Tract Urothelial Carcinoma.Update on chemotherapy in the treatment of urothelial carcinoma
P2860
Q27010323-0E150212-FE08-44A9-99AC-2CF1A36B3E0BQ33394158-678086AC-F14F-435B-A8A0-020901BDF2F9Q33408261-47570944-8614-43E3-9092-E1F386D27BE5Q33418868-A4B6093B-CAD3-4C9A-8DBC-192BCF653FEEQ33431220-62950B51-A283-4AEA-B5C5-64F5D424506EQ33619249-D32A1232-F221-4C8F-A547-76D4FC066018Q34541463-A7EAA426-F026-4A9B-A176-7DB1C053EDD9Q36192053-E4639181-9558-4146-B445-3DA14FC336E4Q36953789-B7047558-967E-4EF8-A2BD-BD5F2870CCC6Q37283592-AA313244-B7F4-45E5-90EB-2F6C4EBA2859Q37284023-C53507D7-5C3D-41D0-B25E-69B695AA836CQ37821892-D57B293B-7E3E-4041-94DE-373351205FBCQ37896172-C8EFE806-6292-4A55-BE89-B79EFC6776E4Q37959263-AEAFBD87-3E84-4C02-A31C-64F8502B4C3BQ38155201-ECA33F9D-7848-4DFD-96DF-8F4B4CA3E0FAQ38612831-5D4B1D49-5D0C-429A-B173-DFA99AAAAD9EQ39352875-BDDAB94D-A9D8-4013-B3BC-D819EF4F4280Q40714083-9F160C62-6C78-4CF8-9410-F0C0EE1D7CE0Q43654255-344051E0-02EE-47E9-AB5A-7AA321EA03DEQ44373064-D914E1AE-7481-426F-AC85-63656A37CBC7Q44750072-EE075D96-C913-4277-920C-A98AFA769058Q53462584-1088A4FC-A7E9-4FFC-8F20-1D96115D20ACQ55287396-939CF500-13E1-4BBB-A090-B0E1EAEA913DQ58694390-692B967F-0F4A-4A9D-A4E2-BBA444544240
P2860
Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Combination of gemcitabine and ...... advanced urothelial carcinoma.
@ast
Combination of gemcitabine and ...... advanced urothelial carcinoma.
@en
type
label
Combination of gemcitabine and ...... advanced urothelial carcinoma.
@ast
Combination of gemcitabine and ...... advanced urothelial carcinoma.
@en
prefLabel
Combination of gemcitabine and ...... advanced urothelial carcinoma.
@ast
Combination of gemcitabine and ...... advanced urothelial carcinoma.
@en
P2093
P356
P1476
Combination of gemcitabine and ...... advanced urothelial carcinoma.
@en
P2093
Kazuyoshi Nakamura
Ken-ichi Egoshi
Kyoko Miyasaka
Masaaki Hamano
Masayuki Maruoka
Naoki Nihei
Satoshi Fukasawa
Takahito Suyama
Takeshi Ueda
Tomohiko Ichikawa
P304
P356
10.1093/JJCO/HYP003
P577
2009-02-10T00:00:00Z